Today at Money20/20, Toronto startup Bionym announced a technology trial that will see users making real life purchases with their heartbeats.

The company’s flagship technology, the Nymi wristband, authenticates wearers persistently based on their unique EKG readings, offering a continuous proximity based identity verification factor. The Nymi is tied to MasterCard and can enable wearable tech payment for users. The new trial will allow customers with bank accounts at the Royal Bank of Canada (RBC) and other participating banks to make biometric payments at point of sale with less risk and only the tap of a wrist.

Andrew D’Souza, Bionym’s president comments: “Payments is a great use-case for persistent identity, because making the experience seamless for consumers is just as important as providing the trust and security that only you can authorize a payment with your account. This could be unlike any other next generation payment mechanism.”